$CMPS soon to support 10-15+ a share... FIRST OF IT'S KIND PSILOCYBIN TREATMENT. Excellent Commercialization Readiness Webcast today for Psilocybin Treatment, with lastest Phase 3 Topline due in Q1 of 2026 ( Last Topline was EXCELLENT). The TEAM IS READY. PLUS BONUS: $CMPS

Palladyne AI will be presenting at the 28th Annual Needham Growth Conference on Jan 14 at 4:30 pm ET. Management will share a company update and host investor meetings. > Webcast: https://t.co/4UQA2qDnup > Press release: https://t.co/GFmDQIxNHd

@gabrelyanov @capybaraReborn Asking for a webcast with stakeholders of @BeyondMeat and they are considering it. Answer immediately. Thank you $bynd. We need shareholders to send a message requesting one. Our voice together matter!

@BelfastGiants your camera work is absolutely shocking. Very amateurish work. To the rest of the teams fans, don't bother with this webcast as you miss half of what is going on.

The weekend is when we get ahead! Research releases today: - Nuclear & Uranium Weekly Roundup - $IMSR Valuation - $ASPI Investor Webcast Prep - Model Fund Weekly Performance Report All research sent here: https://t.co/zPxa6Z4VUo

Look out for Barrick’s Q4 2025 results on February 5. 🕒 6:00 AM ET – Results release 🕒 11:00 AM ET – Results presentation and webcast Register now to attend the webcast 👉 https://t.co/OSnKdNzmir News release 👉 Barrick to Report Full Year and Fourth Quarter 2025 Results on

Size of that scoreboard and clock on the Clan webcast 🤣🤣🤣

Conference call and webcast presentation today, January 7, 2026, at 8:00 a.m. ET. A webcast of the presentation will be accessible via the “Events & Presentations” section of Monte Rosa’s website. https://t.co/wL7bhjiYXO

Live look at Bill Self in the post-game locker room after Kansas loses in the Coliseum.... AGAIN!! 🤣 #WVU

Positive P3 data announced today for envudeucitinib in plaque psoriasis. All endpoints met. Read our release and join the webcast at 8am EST to learn more. https://t.co/RcLE4vuvcM

Is sacituzumab-TMT a game-changer in post-TKI EGFR mutated lung cancer? Sharmistha Ghosh discusses the implications of the Opti-TROP Lung-04 study in the BTOG 'ESMO Top 10' webcast Download the podcast or login to your BTOG account to watch https://t.co/kri6DbE1i7 #LCSM

AHS初売りのSynthesizerV2セットとVoicepeakセットが届きました！ 使い切れる気がしないけど、いっぱいお迎えしちゃいました！ フリモメンカウント10(SV2含む)かぁ。

#AHRQ’s new CAHPS End-of-Life Care Survey helps systematically capture what matters most to patients and families. Join our Jan 15, 2026, webcast, 1–2 pm ET, to explore its design, testing, and early use. #PatientCare https://t.co/Wwf4m9SjXI

Investor News Listen Now: Investor call on Interim Clinical Update from Highest Dose Cohort of Phase 1 CORAL-1 Study Evaluating KB407 in Patients with Cystic Fibrosis Investors and the general public can access the live webcast at https://t.co/RS6GTuiznM

🚨 SOL Strategies Inc. (CSE: HODL | NASDAQ: STKE) reports year-end financial results today, Monday, December 29, 2025. 📅 Don’t miss our live webcast & conference call on Tuesday, January 6, 2026 at 4:30 PM ET, featuring Interim CEO Michael Hubbard, CFO Doug Harris, COO Andrew

Why Acribon Therapeutics Soars? Looking at the Acribon Therapeutics (ACRV) chart, it is up approximately 22.7% at $3.62 today (January 8, 2026) with volume accompanying it. The key reason the stock is currently surging is due to the release and webcast of key clinical data this

The decision to not have any commentary on the SN8 webcast still baffles me. We litterally had no idea if stuff like the engines shutting down one by one was intentional or not, it was so confusing lol.

Mark your calendar - January 2026 - Check the EBS Advisor Webcast schedule (article KB513953) for upcoming and recorded sessions. https://t.co/tcycYkXErm

We've heard a lot from American protestors about the capture of Maduro, but how do Venezuelans feel about it? Watch the rest of this webcast here 👉 https://t.co/48VHNipTep